Overview

A Study of RTA 402 in Obese Adults

Status:
Completed

Trial end date:
2020-06-18

Target enrollment:

Participant gender:

Summary

To investigate changes in body weight and body composition in obese adults after repeated oral administration of RTA 402 once daily for 16 weeks, using placebo as a control.

Phase:

Phase 1

Details

Lead Sponsor:

Kyowa Kirin Co., Ltd.